Stocks
Global Blood Therapeutics (GBT) EBITDA US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -115.4 | -169.6 | -256.8 | -226.9 | -278.5 | -288.4 | ||
| Changes by years, y/y, % | +41% | +47% | +51% | -12% | +23% | +27.7% | |||
Global Blood Therapeutics. EBITDA US GAAP, bln rub
Global Blood Therapeutics. EBITDA US GAAP, changes, %
Global Blood Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Global Blood Therapeutics (GBT) EBITDA US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -63.7 | -65.1 | -81.0 | -70.8 | -71.6 | -288.4 | |
| Changes by years, y/y, % | +31% | +16% | +45% | +2% | +12% | |||
| Changes by quarters, q/q, % | -8% | +2% | +24% | -13% | +1% | |||
